UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection

PLoS neglected tropical diseases, 2019-11, Vol.13 (11), p.e0007890

2019

Volltextzugriff (PDF)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus

Scientific reports, 2023-03, Vol.13 (1), p.4175-12, Article 4175

2023

Volltextzugriff (PDF)

Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways

Viruses, 2024-04, Vol.16 (4), p.635

2024

Volltextzugriff (PDF)

Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease

Viruses, 2024-07, Vol.16 (7), p.1101

2024

Volltextzugriff (PDF)

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

Vaccines (Basel), 2021-05, Vol.9 (5), p.520

2021

Volltextzugriff (PDF)

Natural History of Marburg Virus Infection to Support Medical Countermeasure Development

Viruses, 2022-10, Vol.14 (10), p.2291

2022

Volltextzugriff (PDF)

Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection

Pathogens (Basel), 2021-04, Vol.10 (5), p.509

2021

Volltextzugriff (PDF)

STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV)

Viruses, 2021-07, Vol.13 (7), p.1388

2021

Volltextzugriff (PDF)

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir

Viruses, 2019-02, Vol.11 (2), p.137

2019

Volltextzugriff (PDF)

Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5684-5692

2013

Volltextzugriff (PDF)

Transcriptomic and Innate Immune Responses to Yersinia pestis in the Lymph Node during Bubonic Plague

Infection and Immunity, 2010-12, Vol.78 (12), p.5086-5098

2010

Volltextzugriff (PDF)

373 Identification of potential targets for immunotherapy in a cynomolgus macaque model of Ebola virus disease

Journal of clinical and translational science, 2023-04, Vol.7 (s1), p.111-111

2023

Volltextzugriff (PDF)

Characterization of a Therapeutic Model of Inhalational Anthrax Using an Increase in Body Temperature in New Zealand White Rabbits as a Trigger for Treatment

Clinical and Vaccine Immunology, 2012-09, Vol.19 (9), p.1517-1525

2012

Volltextzugriff (PDF)

Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo

Infection and Immunity, 2005-12, Vol.73 (12), p.8275-8281

2005

Volltextzugriff (PDF)

Mucosal Challenge Ferret Models of Ebola Virus Disease

Pathogens (Basel), 2021-03, Vol.10 (3), p.292

2021

Volltextzugriff (PDF)

Development of an Inhalational Bacillus anthracis Exposure Therapeutic Model in Cynomolgus Macaques

Clinical and Vaccine Immunology, 2012-11, Vol.19 (11), p.1765-1775

2012

Volltextzugriff (PDF)

Repurposing Quinacrine against Ebola Virus Infection In Vivo

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Volltextzugriff (PDF)

Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax

Pathogens (Basel), 2020-10, Vol.9 (11), p.877

2020

Volltextzugriff (PDF)

Physiological Responses to a Single Low-Dose of Bacillus anthracis Spores in the Rabbit Model of Inhalational Anthrax

Pathogens (Basel), 2020-06, Vol.9 (6), p.461

2020

Volltextzugriff (PDF)

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model

Pathogens (Basel), 2020-09, Vol.9 (9), p.773

2020

Volltextzugriff (PDF)

Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques

Journal of virology, 2023-05, Vol.97 (5), p.e0188822-e0188822

2023

Volltextzugriff (PDF)

Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model

Antiviral research, 2023-01, Vol.209, p.105492, Article 105492

2023

Volltextzugriff (PDF)

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

The Journal of infectious diseases, 2019-07, Vol.220 (5), p.735-742

2019

Volltextzugriff (PDF)

Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection

Natural history of nonhuman primates after conjunctival exposure to Ebola virus

Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways

Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease

Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

Natural History of Marburg Virus Infection to Support Medical Countermeasure Development

Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection

STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV)

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir

Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax

Transcriptomic and Innate Immune Responses to Yersinia pestis in the Lymph Node during Bubonic Plague

373 Identification of potential targets for immunotherapy in a cynomolgus macaque model of Ebola virus disease

Characterization of a Therapeutic Model of Inhalational Anthrax Using an Increase in Body Temperature in New Zealand White Rabbits as a Trigger for Treatment

Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo

Mucosal Challenge Ferret Models of Ebola Virus Disease

Development of an Inhalational Bacillus anthracis Exposure Therapeutic Model in Cynomolgus Macaques

Repurposing Quinacrine against Ebola Virus Infection In Vivo

Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax

Physiological Responses to a Single Low-Dose of Bacillus anthracis Spores in the Rabbit Model of Inhalational Anthrax

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model

Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques

Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection

Suchergebnisse filtern